Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02783300 |
| Title | Dose Escalation Study of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma (NHL) |
| Acronym | Meteor 1 |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | NLD | FRA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Denver | Colorado | 80218 | United States | Details | |
| GSK Investigational Site | Miami | Florida | 33136 | United States | Details | |
| GSK Investigational Site | New York | New York | 10065 | United States | Details | |
| GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details | |
| GSK Investigational Site | Dallas | Texas | 75230 | United States | Details | |
| GSK Investigational Site | San Antonio | Texas | 78229 | United States | Details | |
| GSK Investigational Site | Edmonton | Alberta | T6G 1Z2 | Canada | Details | |
| GSK Investigational Site | Ottawa | Ontario | K1H 8L6 | Canada | Details | |
| GSK Investigational Site | Toronto | Ontario | M5G 1Z5 | Canada | Details | |
| GSK Investigational Site | Bordeaux | 33076 | France | Details | ||
| GSK Investigational Site | Lyon | 69373 | France | Details | ||
| GSK Investigational Site | Villejuif | 94805 | France | Details | ||
| GSK Investigational Site | Amsterdam | 1066 CX | Netherlands | Details | ||
| GSK Investigational Site | Leiden | 2333 ZA | Netherlands | Details | ||
| GSK Investigational Site | Rotterdam | 3015 GD | Netherlands | Details |